These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 17892927)

  • 1. Intra-arterial and systemic chemotherapy plus external hyperthermia in unresectable biliary cancer.
    Mambrini A; Del Freo A; Pacetti P; Orlandi M; Torri T; Fiorentini G; Cantore M
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):805-6. PubMed ID: 17892927
    [No Abstract]   [Full Text] [Related]  

  • 2. Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study.
    Mambrini A; Guglielmi A; Pacetti P; Iacono C; Torri T; Auci A; Nicoli N; Orlandi M; Guadagni S; Fiorentini G; Cantore M
    Anticancer Res; 2007; 27(4C):3009-13. PubMed ID: 17695488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
    Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
    Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine.
    Pacetti P; Giovannetti E; Mambrini A; Nannizzi S; Orlandi M; Tartarini R; Del Freo A; Del Tacca M; Danesi R; Cantore M
    Anticancer Res; 2009 May; 29(5):1835-40. PubMed ID: 19443413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
    Hong YS; Lee J; Lee SC; Hwang IG; Choi SH; Heo JS; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):321-8. PubMed ID: 17143602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatic arterial chemotherapy combined with hyperthermia or arterial embolization in unresectable liver tumor].
    Hamazoe R; Koga S; Maeda M; Shimizu N; Shimizu T; Sawata T; Ishiguro M; Inoue Y; Wakatsuki T; Murakami A
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2590-5. PubMed ID: 2843128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic gemcitabine and capecitabine plus intra-arterial epirubicin and cisplatin as second-line chemotherapy in gemcitabine-failure pancreatic cancer.
    Mambrini A; Bassi C; Torri T; Orlandi M; Fiorentini G; Cantore M
    Pancreas; 2011 Aug; 40(6):983-4. PubMed ID: 21562443
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional combined with systemic chemotherapy in unresectable biliary tract cancers: a phase II study.
    Cantore M; Fiorentini G; Mambrini A; Rabbi C; Zamagni D; Carlone N; Manni A; Caudana R; Torri T
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):59-64. PubMed ID: 16767908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional chemotherapy in biliary tract cancers--a single institution experience.
    Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z
    Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A prospective randomized clinical trial comparing intra-arterial chemotherapy alone and when combined with hyperthermia for metastatic liver cancer].
    Kondo M; Itani K; Yoshikawa T; Tanaka Y; Watanabe N; Hiraoka M; Noguchi M; Miura K
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1807-11. PubMed ID: 7574814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma.
    Park SH; Park YH; Lee JN; Bang SM; Cho EK; Shin DB; Lee JH
    Cancer; 2006 Jan; 106(2):361-5. PubMed ID: 16342166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer.
    Morizane C; Okada S; Okusaka T; Ueno H; Saisho T
    Oncology; 2003; 64(4):475-6. PubMed ID: 12759549
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer.
    Ocvirk J; Reberšek M; Skof E; Hlebanja Z; Boc M
    Am J Clin Oncol; 2012 Jun; 35(3):237-41. PubMed ID: 21399488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for biliary tract cancer in Japan.
    Okusaka T
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):51-3. PubMed ID: 12577234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer.
    Yun J; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK
    Eur J Cancer; 2010 Mar; 46(5):885-91. PubMed ID: 20060288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
    Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
    Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5 -fluoropyrimidines for treatment of biliary tract cancers].
    Morizane C; Okusaka T; Ueno H; Ikeda M
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():529-33. PubMed ID: 16457319
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiotherapy and concomitant intra-arterial docetaxel combined with systemic 5-fluorouracil and cisplatin for oropharyngeal cancer: a preliminary report--improvement of locoregional control of oropharyngeal cancer.
    Oikawa H; Nakamura R; Nakasato T; Nishimura K; Sato H; Ehara S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):338-42. PubMed ID: 19735860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
    Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.